Cadence Bank Na Abbott Laboratories Transaction History

Cadence Bank Na

$16.1 Million
Q3 2022

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$102.07 - $123.37 $141,060 - $170,497	-1,382 Reduced 3.69%	36,040 $3.92 Million
Q1 2022 Apr 18, 2022	SELL	$114.02 - $139.04 $7,183 - $8,759	-63 Reduced 0.17%	37,422 $4.43 Million
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $53,374 - $65,354	-462 Reduced 1.22%	37,485 $5.28 Million
Q3 2021 Oct 22, 2021	SELL	$116.66 - $129.06 $70,579 - $78,081	-605 Reduced 1.57%	37,947 $4.48 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $63,474 - $74,718	-600 Reduced 1.53%	38,552 $4.47 Million
Q1 2021 May 05, 2021	BUY	$108.84 - $128.23 $24,489 - $28,851	225 Added 0.58%	39,152 $4.69 Million
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $129,465 - $141,079	1,233 Added 3.27%	38,927 $4.26 Million
Q3 2020 Oct 23, 2020	SELL	$91.64 - $111.29 $4,856 - $5,898	-53 Reduced 0.14%	37,694 $4.1 Million
Q2 2020 Jul 31, 2020	BUY	$76.57 - $98.0 $9,418 - $12,054	123 Added 0.33%	37,747 $3.45 Million
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $367,434 - $537,289	-5,849 Reduced 13.45%	37,624 $2.97 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $309,093 - $344,093	3,937 Added 9.96%	43,473 $3.78 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $8,838 - $9,583	108 Added 0.27%	39,536 $3.31 Million
Q2 2019 Aug 06, 2019	SELL	$72.88 - $85.0 $239,265 - $279,055	-3,283 Reduced 7.69%	39,428 $3.32 Million
Q1 2019 May 09, 2019	SELL	$66.22 - $80.06 $151,312 - $182,937	-2,285 Reduced 5.08%	42,711 $3.42 Million
Q4 2018 Feb 08, 2019	BUY	$65.56 - $74.27 $30,813 - $34,906	470 Added 1.06%	44,996 $3.25 Million
Q3 2018 Nov 06, 2018	BUY	$60.81 - $73.36 $44,695 - $53,919	735 Added 1.68%	44,526 $3.27 Million
Q2 2018 Aug 07, 2018	SELL	$57.57 - $63.54 $168,161 - $185,600	-2,921 Reduced 6.25%	43,791 $2.67 Million
Q1 2018 May 04, 2018	SELL	$56.27 - $63.62 $213,600 - $241,501	-3,796 Reduced 7.52%	46,712 $2.8 Million
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $49,546 - $53,044	-923 Reduced 1.79%	50,508 $2.88 Million
Q3 2017 Oct 27, 2017	BUY	$48.06 - $53.64 $2.47 Million - $2.76 Million	51,431	51,431 $2.74 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.5 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.05 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.76 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.29 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank Na with notifications on news.

Account